Robert M Caudle Selected Research

nornicotine

4/2007	Expression of the receptor of advanced glycation end products in the gingival tissue of smokers with generalized periodontal disease and after nornicotine induction in primary gingival epithelial cells.
7/2005	Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert M Caudle Research Topics

Disease

12	Pain (Aches) 01/2020 - 09/2003
8	Hyperalgesia 01/2020 - 08/2005
8	Hypersensitivity (Allergy) 09/2010 - 01/2006
7	Inflammation (Inflammations) 01/2015 - 08/2005
4	Colitis 01/2015 - 10/2006
3	Facial Pain (Myofacial Pain) 01/2016 - 12/2006
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015 - 01/2006
2	Chronic Pain 11/2013 - 09/2005
2	Visceral Pain 01/2008 - 09/2007
2	Periodontal Diseases (Periodontal Disease) 04/2007 - 07/2005
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pathologic Processes 01/2020
1	Headache (Headaches) 01/2020
1	Migraine Disorders (Migraine) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Multiple Myeloma 12/2017
1	Weight Loss (Weight Reduction) 01/2015
1	Neuralgia (Stump Neuralgia) 11/2013
1	Immersion Foot (Trench Foot) 06/2013
1	Cold Hypersensitivity 09/2010
1	Neurogenic Inflammation 10/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2003

Drug/Important Bio-Agent (IBA)

6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2009 - 09/2003
5	Analgesics (Analgesic Drugs)IBA 10/2012 - 08/2005
4	Sulfonic AcidsIBA 01/2015 - 10/2006
4	Capsaicin (Zostrix)FDA Link 01/2014 - 06/2006
4	Morphine (MS Contin)FDA LinkGeneric 10/2012 - 08/2005
4	N-Methylaspartate (NMDA)IBA 09/2009 - 01/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2013
2	resiniferatoxinIBA 01/2018 - 09/2009
2	Advanced Glycation End ProductsIBA 12/2017 - 04/2007
2	Opioid Analgesics (Opioids)IBA 12/2015 - 06/2013
2	Menthol FDA Link 01/2014 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 07/2009 - 09/2005
2	Ethanol (Ethyl Alcohol)IBA 02/2008 - 01/2008
2	nornicotineIBA 04/2007 - 07/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Blood Proteins (Serum Proteins)IBA 01/2015
1	A 17 (A-17)IBA 01/2014
1	Transient Receptor Potential ChannelsIBA 01/2014
1	NeuropeptidesIBA 11/2013
1	incobotulinumtoxinA FDA Link 11/2013
1	Botulinum Toxins (Botulinum Toxin)IBA 11/2013
1	SugarsIBA 06/2013
1	Naltrexone (ReVia)FDA LinkGeneric 06/2013
1	Naloxone (Narcan)FDA LinkGeneric 09/2010
1	mu Opioid Receptors (mu Opioid Receptor)IBA 09/2010
1	TRPV1 receptorIBA 09/2009
1	PAR-2 ReceptorIBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Opioid Receptors (Opioid Receptor)IBA 09/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 09/2007
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 05/2007
1	Dihydrotachysterol (AT 10)IBA 12/2006
1	Serine (L-Serine)FDA Link 09/2005
1	CarrageenanIBA 09/2005

Therapy/Procedure

3	Analgesia 01/2018 - 10/2012
2	Therapeutics 01/2020 - 09/2005
1	Axotomy 01/2018
1	Bite Force (Occlusal Forces) 12/2008
1	Injections 09/2003